Institutions / Sofinnova Investments, Inc.
Sofinnova Investments, Inc.
CIK 1631134 · Institution · as of Dec 31, 2025
Portfolio value
$2.32B
Positions
60
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 60 →
| Company | Value | % of portfolio |
|---|---|---|
| Natera, Inc. | $355.15M | 15.3% |
| Jazz Pharmaceuticals PLC | $163.18M | 7.0% |
| Astrazeneca PLC | $150.06M | 6.5% |
| Vera Therapeutics, Inc. | $141.49M | 6.1% |
| Bristol Myers Squibb Co | $81.61M | 3.5% |
| United Therapeutics Corp | $76.81M | 3.3% |
| Vertex Pharmaceuticals Inc / Ma | $74.62M | 3.2% |
| AbbVie Inc. | $72.61M | 3.1% |
| Intuitive Surgical Inc | $71.91M | 3.1% |
| Cogent Biosciences, Inc. | $70.10M | 3.0% |
| ELI LILLY & Co | $66.26M | 2.9% |
| Rapport Therapeutics, Inc.RAPP | $57.78M | 2.5% |
| BridgeBio Pharma, Inc. | $55.11M | 2.4% |
| Avidity Biosciences, Inc. | $53.75M | 2.3% |
| Dyne Therapeutics, Inc. | $44.09M | 1.9% |
| BioMarin Pharmaceutical Inc | $41.43M | 1.8% |
| Apogee Therapeutics, Inc. | $40.37M | 1.7% |
| Cidara Therapeutics Inc | $39.82M | 1.7% |
| Praxis Precision Medicines, Inc. | $37.06M | 1.6% |
| Immatics N.V | $36.07M | 1.6% |
| Inhibrx Biosciences, Inc. | $35.92M | 1.5% |
| Immunome Inc. | $34.76M | 1.5% |
| Arrivent Biopharma IncAVBP | $34.14M | 1.5% |
| Glaukos Corp | $32.53M | 1.4% |
| Ideaya Biosciences, Inc. | $30.60M | 1.3% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.